Sight Sciences (Nasdaq:SGHT) announced that it appointed Alison “Ali” Bauerlein as its chief financial officer and treasurer. Bauerlein’s appointment became effective on April 3. She joins from Inogen, having cofounded the medtech company in 2001 and served as CFO from 2009 through 2021. In that role, she oversaw the global finance and accounting functions, helping […]
Sight Sciences
Axonics, Outset lead medtech space on Deloitte’s list of fastest growing companies
Deloitte today released its “North America Technology Fast 500” list of growing companies, including a handful of medtech firms. The list, which ranking of the fastest-growing North American companies across a range of sectors, included several “Life Sciences” outfits. Immunology company Vir Biotechnology led the way in first place on the list. Axonics (Nasdaq:AXNX) represented […]
5 top ophthalmic device innovations you need to know
Innovation finds its way into all areas of medtech, and ophthalmic treatments represent another burgeoning space. It may not be a new wave, but medtech companies continue to improve upon technologies for the human eye. Implants, lenses and more comprise the space’s latest innovations, with a number of companies finding new ways to fix old […]
Data supports Sight Sciences’ Omni surgical system for glaucoma
Sight Sciences (Nasdaq:SGHT) announced today that 36-month data supports the use of its Omni surgical system. Data from the three-year post-surgery follow-up demonstrates that the Omni surgical system delivers safe, consistent and durable results in adult patients with open-angle glaucoma (OAG) on a standalone basement. Menlo Park, California–based Sight Sciences evaluated the Omni system in […]
Sight Sciences touts positive study results of dry eye treatment device
Sight Sciences today announced positive results from a clinical trial of its TearCare wearable eyelid technology. The Olympia study was a prospective, randomized multicenter trial that enrolled 235 dry eye patients across 10 sites in the U.S. The goal was to demonstrate the safety and effectiveness of a single TearCare procedure compared to the LipiFlow […]
Sight Sciences raises $30m in Series E round
Growth-stage ophthalmology and optometry device developer Sight Sciences announced today that it closed a Series E preferred stock financing round totaling over $30 million. The Menlo Park, Calif.–based company — which develops treatments for glaucoma and dry eye disease — said in a news release that the proceeds from the funding are earmarked for clinical […]
Sight Sciences raises $31m in Series D funding
Sight Sciences said today that it closed a Series D funding round of more than $30 million. The financing, led by KCK Group, totaled $31 million for the Menlo Park, Calif.-based company that specializes in devices for micro-invasive glaucoma surgery (MIGS) and in treatments for dry eye disease. The company initially said it had pulled […]
Sight Sciences adds $31m
Sight Sciences pulled in an equity round worth nearly $31 million for the ophthalmological devices it’s developing, the company said yesterday. Menlo Park, Calif.-based Sight Sciences logged the first sale of the round August 9, according to a regulatory filing, raising $30.7 million of a hoped-for $31.5 million. Two unnamed investors participated in the round, […]
Sight Sciences launches Omni eye surgery study
Sight Sciences said today that it launched a clinical trial of its Omni eye surgery device in sequential, minimally invasive glaucoma procedures. Menlo Park, Calif.-based Sight Sciences said the 130-patient Gemini study is designed to evaluate the use of Omni in consecutive MIGS procedures involving transluminal viscoelastic delivery and trabeculotomy at 12 months. The single-arm […]
Philips board backs reappointment of CEO van Houten, CFO Bhattacharya | Personnel Moves – October 29, 2018
Royal Philips (NYSE:PHG) said today that its board of directors is backing the re-appointment of Frans van Houten as its president and CEO and Abhijit Bhattacharya as chief financial officer and board member. CEO van Houten has been at the head of Philips since 2011, while Bhattacharya joined the company in 2015, Amsterdam-based Philips said. During […]
Sight Sciences launches pivotal trial of TearCare dry-eye disease treatment
Ophthalmic medical device company Sight Sciences today announced the launch of a new pivotal trial exploring the safety and effectiveness of its TearCare system in patients with dry eye disease. The Menlo Park, Calif.-based company’s TearCare system is a wearable therapeutic eyelid technology designed to deliver energy over a specified period to liquify meibum, an oily coating […]
